Suppliers / Varichem Pharmaceuticals

Varichem Pharmaceuticals

Zimbabwe 159 employees Updated 9 July 2026

Varichem Pharmaceuticals is a finished-dose manufacturer based in Zimbabwe. It appears in 199 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with MCAZ (ZW), NMRC (NA) and TMDA (TZ). Its most recent recorded inspection, by ANSM (FR), closed on 28 January 2025 as NAI.

0
active US DMFs
0
valid CEPs
2
registered plants
199
filings across 5 regulators

Inspection history

  • 28 January 2025 NAI ANSM (FR)

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
HARARE, Zimbabwe Not on file
HARARE, Zimbabwe Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
MCAZ (ZW) 150 None
NMRC (NA) 36 None
TMDA (TZ) 5 None
BOMRA (BW) 4 None
ZAMRA (ZM) 4 None

Questions about Varichem Pharmaceuticals

Does Varichem Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Varichem Pharmaceuticals. It does have 199 filings with 5 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
How did Varichem Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 28 January 2025 as NAI (No Action Indicated: nothing objectionable was found). 1 inspection is on file.
Where does Varichem Pharmaceuticals manufacture?
2 registered sites are on record, in Zimbabwe (Harare among others). Every site is listed on this page with the register it came from.
Where does Varichem Pharmaceuticals file?
Filings are on record with MCAZ (ZW), NMRC (NA), TMDA (TZ), BOMRA (BW) and 1 other regulator, 199 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Varichem Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 28 January 2025.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability